HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

LATAM OTC Results Round-Up: Mexico's Genomma Lab, Brazil's Hypera

Executive Summary

Genomma enjoys broad-based growth in 2018, while NPD investments pay off for Hypera.

You may also be interested in...



Sanofi Partners With Colombian Tech Firm Rappi To 'Transform' Healthcare In Latin America

Sanofi Consumer Healthcare is utilizing emerging digital technology to take a bigger slice of the Latin American OTC market. Through a partnership deal, e-commerce and delivery firm Rappi will promote and sell Sanofi's brands to consumers across seven Latin American markets. 

People On The Move: Appointments At UPSA, Bionorica And MHRA

The latest European consumer health people news: Sanofi Consumer Healthcare's Van Rycke named CEO of UPSA; Bionorica's global business head steps down; MHRA names its first chief safety officer.

Swisse Pens Deal To Use ChromaDex’ Niagen In Supplements

Australian-heritage supplements brand Swisse has secured the rights to use ChromaDex' patented Niagen ingredient - marketed to help consumers "age better" - in a new product range.

Topics

Related Companies

UsernamePublicRestriction

Register

RS148665

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel